News Oct 31, 2024
Milestone | Comprehensive Enhancement of GMP Manufacturing Capacity and New Modality Service Capabilities at Porton Fengxian, Shanghai
Recently, Porton Pharma has achieved a significant capacity breakthrough at its GMP manufacturing facility in Fengxian, Shanghai, China, further enhancing its production capabilities and technological strength in new modality areas such as peptide and oligonucleotide drugs. This upgrade represents an important step in Porton's commitment to becoming a leading global CDMO company.
News Oct 24, 2024
Porton Pharma Solutions Signed Strategic Partnership with Shanghai InnoStar
On October 24, 2024, Porton Pharma SolutionsLtd. ("Porton") announced a strategic partnership with Shanghai InnoStar Bio-tech Co., Ltd. ("InnoStar") in Shanghai. The distinguished signing ceremony was attended by Mr. Ju Nianfeng, Chairman and CEO of Porton; Dr. Chang Yan, President of InnoStar; Ms. Pi Wei, Deputy General Manager of Porton; Ms. Fan Meng, Deputy General Manager of the Sales & Marketing Center, Dr. Fang Xin, Senior Director of Non-clinicalPharmacology BU at InnoStar, and Ms. Zhao Jie, Marketing Associate Director at InnoStar.
News Oct 14, 2024
Driving innovation and excellence in the CDMO industry, Porton Pharma Solutions 2024 CPHI Europe Review
Recently, the three-day 2024 CPHI Milan exhibition concluded successfully in Milan, Italy. As a leading global platform for showcasing the most advanced development of pharmaceutical industry , the event attracted numerous international pharmaceutical and biopharmaceutical companies.
News Oct 10, 2024
Connect with Porton J-STAR at AAPS PharmSci 360 2024 @ Booth 2431
The AAPS PharmSci 360, held from October 20-23, 2024, is an eminent event in the pharmaceutical industry, renowned for its convergence of key players, thought leaders, and innovative companies from across the globe. This year, Porton J-STAR invites you to connect with us at Booth 2431, where we will be exhibiting our end-to-end global CDMO service capabilities across both drug substance and drug product development and manufacturing, and the differentiated advantages these services offer to customers.
News Sep 30, 2024
Technical Enability | Porton’s Team of Global Chemical Engineering and Technology Published Breakthrough Results in Crystal Growth & Design and reported them at the 2024 Crystal Engineering Gordon Research Conference
Technology-Driven | Porton’s Team of Global Chemical Engineering and Technology Published Breakthrough Results in Crystal Growth & Design and reported them at the 2024 Crystal Engineering Gordon Research Conference
News Sep 19, 2024
Porton Showcases At CPhI Europe, Meeting Your CDMO Experts In Booth 5C17
CPhI Europe stands as a worldwide event in the pharmaceutical industry, bringing together key players, thought leaders, and businesses from across the globe. The event serves as an unparalleled platform for powerful networking, fostering collaborations, and driving forward the growth and innovation of the pharmaceutical sector.
News Sep 19, 2024
Presenter Profile Reveal, Meeting Your CDMO Experts In Booth 5C17
In an effort to foster stronger interactions with industry professionals, we have organized two dedicated presentation sessions at booth 5C17 on October 9. Our expert speakers will deliver advanced technical insights and industry perspectives, offering attendees a deep dive into the latest developments.
News Sep 13, 2024
Keep hope alive! We invite you to stay tuned to DMD
From September 6 to 7 2024, the Porton Wecare Program accompanied the families of four Chongqing DMD patients to Shanghai to participate in the 13th China Rare Disease Summit 2024.The summit, co-sponsored by the Chinese Organization for Rare Disorders (CORD) and Xinhua Hospital affiliated with Shanghai Jiaotong University School of Medicine, was held from September 6 to 8, 2024.
News Sep 09, 2024
Join Porton and Industry Elites at Pharma Crystallization Summit 2024!
The Full Agenda for the PCS 2024 is Now Available.
